Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +26.3% | +79.3% | 3 / 3 | +8.9% | +2.26 pp | +4.35 pp | +23.9% | 0.77 | 5.28 | 95,7 | +8,9% | 30,1 | +26,3% | 5.28 | 10.21 | −48,3% |
| Pts | 4 | 12 | 12 | 0 | 8 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 17.400 (close price on 2026-10-19)EPS (TTM): 3.297
Financial charts
1.Revenue & growth
VND bn95,7Q2/26
1.Revenue & growth
VND bn95,7Q2/26
2.Profit & growth
VND bn30,1Q2/26
3.Profit mix (Penman)
VND bn117Q2/26
4.Margins & cost structure
%60.9%Q2/26
5.Returns & cash cycle
% · days20.3%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn881Q2/26
8.Funding & debt health
VND bn · times881Q2/26
9.Revenue backlog
VND bn0,70Q2/26
10.Valuation
times · %5,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %954Q2/26
Adjusted EPS growth, latest quarter
26.3%
Average adjusted EPS growth, 3 quarters
79.3%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26